PCR63 Using Patient Preference to Inform Ritlecitinib Dose Selection for Alopecia Areata Treatment

Abstract

Authors

B Hauber C Whichello J Mauer E Law M Trapali EP Whalen D Wajsbrot N Krucien T Tervonen S Zwillich R Wolk

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×